Introduction
Team RoSynth understands the critical significance of adhering to stringent safety protocols. By meticulously following these guidelines, we ensure the well-being of our team members and the broader community while conducting cutting-edge research in synthetic biology. Our commitment to safety not only fosters a culture of responsibility and professionalism, but also allows us to carry out experiments with the highest level of precision and confidence. In doing so, we can advance our understanding of synthetic biology and contribute to the development of innovative solutions that benefit society while minimizing any potential risks associated with our work.
Safe Experimental Design
We implemented several safety features and made design decisions to mitigate potential risks:
Non-Pathogenic Chassis
We consciously selected non-pathogenic strains of yeast (S. cerevisiae) and bacteria (Dh5α and BL21 E. coli) as our chassis organisms. By using microorganisms generally recognized as safe, we minimize the risk of accidental infections or harm to humans, animals, or plants.
Safe Genetic Parts
Our choice of genetic parts and components is based on their proven safety record. We have carefully screened and selected genetic elements that are known to be non-toxic and non-harmful, reducing the possibility of unintended negative consequences. The plasmids we are using contain safe insert protein-coding genes, all naturally occurring enzymes: HpaBC, D-LDH, TAL, 4CL, TyrB, and rosmarinic acid synthase (RAS).
The functions of these enzymes are as follows:
- HpaBC genes express a 4-hydroxyphenylacetate 3-monooxygenase reductase complex. This complex converts 4-hydroxyphenylpyruvate into 4-dihydroxyphenyllactate by adding a hydroxyl group to the benzene ring.
- D-LDH genes express lactate dehydrogenase which carries a reduction reaction, converting a carbon double-bonded oxygen to a carbon-bonded hydroxyl group to convert 4-dihydroxyphenyllactate into salvianic acid A.
- TyrB genes express tyrosine aminotransferase. This protein converts 4-hydroxyphenylpyruvate into L-tyrosine. The TAL genes express tyrosine ammonia lyase. This protein converts L-tyrosine into p-coumaric acid.
- 4CL genes express 4-coumaroyl CoA-ligase. This protein converts caffeic acid to caffeoyl CoA.
- RAS genes express rosmarinic acid synthase. This protein fuses caffeoyl CoA and salvianic acid A to produce rosmarinic acid.
Substituting with Safer Materials:
In our proof-of-concept experiments, we have taken steps to replace potentially dangerous materials with safer alternatives. For instance, we have opted for non-toxic hydrogel materials that are biocompatible, ensuring that any accidental contact or exposure poses minimal risk. Additionally, we have decided to synthesize rosmarinic acid as our proof of concept because this molecule does not pose a significant threat to humans and has very low toxicity. Our original idea was to synthesize a medical compound such as papaverine, but that could pose a threat since they are regulated molecules and should not be synthesized outside of authorized facilities that have better means of containment.
By incorporating these safety features and making thoughtful design decisions, our project is not only innovative but also responsible and considerate of potential risks, ensuring that our research in synthetic biology remains safe and secure throughout its development.
Laboratory Safety Procedures
In our Rochester iGEM laboratory, safety procedures are a fundamental part of our daily operations. Given the complexity and ambition of our project to optimize plant-based chemical production using a co-culture of bacteria and yeast through bioprinting, we are particularly diligent about adhering to safety protocols. Some of the safety procedures we employ include:
Personal Protective Equipment (PPE):
Team members are required to wear appropriate PPE, including lab coats and gloves, to minimize the risk of exposure to chemicals and biological materials. Additionally, team members are required to wear safety goggles when working on hardware and when they perform organic chemistry procedures such as preparing the HPLC samples and handling strong acids. Fume hoods were also used when handling strong acids, fumes, or boiling liquids.
Sterile Techniques:
We maintained strict sterile techniques to prevent contamination when handling microorganisms, including the modified yeast and bacteria used in our project. To discard liquid contaminated samples, they were mixed with bleach to a concentration of 10%, then diluted with water and poured in the sink. Solid contaminated waste was autoclaved before disposal.
Chemical Handling:
Chemicals are handled with care, following established protocols for storage, disposal, and dilution. We are mindful of the potential hazards of chemicals used in our experiments.
Waste Disposal:
The University of Rochester has a rigorous waste disposal system in place to ensure that all biohazardous and chemical waste is properly disposed of according to regulations.
Safety in Bioprinting
The integration of 3D bioprinting technology into our project brings some unique safety considerations. Ensuring the safety of both team members and the environment when working with the bioprinter and modified microorganisms is paramount. We have taken additional precautions such as conducting risk assessments for potential printer malfunctions and developing emergency shutdown procedures. This ensures that any unusual issues related to the bioprinter's hardware can be promptly addressed to prevent accidents or contamination. The microbe-laden hydrogels are contained within glass syringes then are extruded through plastic tubes and are printed into a Petri dish. After printing, the glass syringes are sterilized using a solution of bleach, and the Petri dish and tubes can be discarded with solid waste. The microbes do not come in contact with any other part of the printer, and the printer is sanitized using a solution of 70% ethanol after and before each print. In case of emergency, the printer can be shut down using the M199 Gcode command as well as the power switch or main LCD board.
In our wet lab, we are constantly vigilant about cross-contamination between our bacteria and yeast strains. Strict segregation and labeling procedures have been put in place to minimize any inadvertent mixing of these microorganisms. We also use different water baths for the bacteria and yeast.
Overall, the safety of our team members, the environment, and the success of our project are our utmost priorities, and we remain dedicated to upholding the highest safety standards throughout our iGEM journey.